cost considerations of multidrug regimens in mm
Published 5 years ago • 24 plays • Length 7:50Download video MP4
Download video MP3
Similar videos
-
5:49
patient cost implications in multiple myeloma treatment
-
6:56
cost effectiveness comparison of belantamab mafodotin and selinexor in rrmm
-
10:09
what is the cost of recurrence in multiple myeloma?
-
2:45
value and cost of multiple myeloma therapy
-
4:12
ocm ensures better outcomes and automatic cost savings in multiple myeloma
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
5:19
a 17-year fight against multiple myeloma
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
4:56
value and cost in mm treatment
-
6:44
factoring age into frontline therapy for mm
-
1:07
drug cost vs. toxicity in mm
-
7:10
practical implications of the maia study for mm
-
2:00
cost-effectiveness of mm treatment
-
1:00
new treatment regimens used to provide maximum benefit in multiple myeloma
-
7:45
extrapolating from clinical trials: daratumumab in mm
-
3:01
mm treatment in the us vs. europe: multi-drug regimens & cellular therapies
-
0:52
dr jeff sharman: cost of therapy is a major challenge in cll
-
1:13
dr. weber on growing costs with triplet and four-drug regimens in melanoma
-
4:33
making sense of the many treatment options for relapsed mm: cost-effectiveness
-
6:44
treatment for multiple myeloma
-
6:13
what is the best treatment regimen for mm?
-
40:06
multiple myeloma: a pathway to better outcomes